616 related articles for article (PubMed ID: 25812115)
21. Differentiation of Intrahepatic Cholangiocellular Carcinoma from Hepatocellular Carcinoma in the Cirrhotic Liver Using Contrast-enhanced MR Imaging.
Wengert GJ; Baltzer PAT; Bickel H; Thurner P; Breitenseher J; Lazar M; Pones M; Peck-Radosavljevic M; Hucke F; Ba-Ssalamah A
Acad Radiol; 2017 Dec; 24(12):1491-1500. PubMed ID: 28756085
[TBL] [Abstract][Full Text] [Related]
22. Dynamic enhancement pattern of intrahepatic cholangiocarcinoma on contrast-enhanced ultrasound: the correlation with cirrhosis and tumor size.
Lu Q; Xue LY; Wang WP; Huang BJ; Li CX
Abdom Imaging; 2015 Aug; 40(6):1558-66. PubMed ID: 25725793
[TBL] [Abstract][Full Text] [Related]
23. Liver tumor characterization--review of the literature.
Dietrich CF; Maddalena ME; Cui XW; Schreiber-Dietrich D; Ignee A
Ultraschall Med; 2012 Jul; 33 Suppl 1():S3-10. PubMed ID: 22723026
[TBL] [Abstract][Full Text] [Related]
24. Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers.
Xu J; Igarashi S; Sasaki M; Matsubara T; Yoneda N; Kozaka K; Ikeda H; Kim J; Yu E; Matsui O; Nakanuma Y
Liver Int; 2012 Aug; 32(7):1156-64. PubMed ID: 22417172
[TBL] [Abstract][Full Text] [Related]
25. Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis.
Iavarone M; Piscaglia F; Vavassori S; Galassi M; Sangiovanni A; Venerandi L; Forzenigo LV; Golfieri R; Bolondi L; Colombo M
J Hepatol; 2013 Jun; 58(6):1188-93. PubMed ID: 23485522
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of contrast-enhanced ultrasound in distinguishing small (≤3 cm) hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
Shin SK; Choi DJ; Kim JH; Kim YS; Kwon OS
Medicine (Baltimore); 2018 Oct; 97(41):e12781. PubMed ID: 30313099
[TBL] [Abstract][Full Text] [Related]
27. Liver tumor characterization--comments and illustrations regarding guidelines.
Dietrich CF
Ultraschall Med; 2012 Jul; 33 Suppl 1():S22-30. PubMed ID: 22723025
[TBL] [Abstract][Full Text] [Related]
28. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.
Li F; Li Q; Liu Y; Han J; Zheng W; Huang Y; Zheng X; Cao L; Zhou JH
Eur Radiol; 2020 Jan; 30(1):461-470. PubMed ID: 31297632
[TBL] [Abstract][Full Text] [Related]
29. Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma.
Viganò L; Lleo A; Muglia R; Gennaro N; Samà L; Colapietro F; Roncalli M; Aghemo A; Chiti A; Di Tommaso L; Solbiati L; Colombo M; Torzilli G
Updates Surg; 2020 Jun; 72(2):413-421. PubMed ID: 32323164
[TBL] [Abstract][Full Text] [Related]
30. Combined Hepatocellular Cholangiocarcinoma (Biphenotypic) Tumors: Potential Role of Contrast-Enhanced Ultrasound in Diagnosis.
Li F; Han J; Han F; Wang JW; Luo RZ; Li AH; Zhou JH
AJR Am J Roentgenol; 2017 Oct; 209(4):767-774. PubMed ID: 28777653
[TBL] [Abstract][Full Text] [Related]
31. Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT.
Chen LD; Xu HX; Xie XY; Lu MD; Xu ZF; Liu GJ; Liang JY; Lin MX
Br J Radiol; 2008 Nov; 81(971):881-9. PubMed ID: 18941048
[TBL] [Abstract][Full Text] [Related]
32. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.
Vidili G; Arru M; Solinas G; Calvisi DF; Meloni P; Sauchella A; Turilli D; Fabio C; Cossu A; Madeddu G; Babudieri S; Zocco MA; Iannetti G; Di Lembo E; Delitala AP; Manetti R
World J Gastroenterol; 2022 Jul; 28(27):3488-3502. PubMed ID: 36158272
[TBL] [Abstract][Full Text] [Related]
33. Contrast-Enhanced Ultrasound Patterns for the Non-invasive Diagnosis of Hepatocellular Carcinoma: A Prospective Multicenter Study in Histologically Proven Liver Lesions in a Real-Life Setting Demonstrating the Benefit of Extended Late Phase Observation.
Schellhaas B; Bernatik T; Dirks K; Jesper D; Mauch M; Potthoff A; Zimmermann P; Strobel D
Ultrasound Med Biol; 2021 Nov; 47(11):3170-3180. PubMed ID: 34417066
[TBL] [Abstract][Full Text] [Related]
34. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
35. Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound.
Kong WT; Wang WP; Huang BJ; Ding H; Mao F
J Gastroenterol Hepatol; 2014 Mar; 29(3):576-80. PubMed ID: 24118042
[TBL] [Abstract][Full Text] [Related]
36. Differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound: A systematic review and meta-analysis.
Chen Y; Zhu Y; Chen K; Wang H; Zhang W; Bao J; Wang W
Clin Hemorheol Microcirc; 2021; 79(2):293-309. PubMed ID: 33935070
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
38. Interobserver Agreement for Contrast-Enhanced Ultrasound (CEUS)-Based Standardized Algorithms for the Diagnosis of Hepatocellular Carcinoma in High-Risk Patients.
Schellhaas B; Pfeifer L; Kielisch C; Goertz RS; Neurath MF; Strobel D
Ultraschall Med; 2018 Dec; 39(6):667-674. PubMed ID: 29879746
[TBL] [Abstract][Full Text] [Related]
39. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent.
Xu HX; Liu GJ; Lu MD; Xie XY; Xu ZF; Zheng YL; Liang JY
J Clin Ultrasound; 2006; 34(6):261-72. PubMed ID: 16788957
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
